Company / Income Tax per Share
Immunovant, Inc. Income Tax per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.01
FY2024
5-year range
-$0.00 / $0.01
FY2020-FY2024
Trend
+43.2%
vs FY2023
Sector context
#85 of 199
Health Care
What the data says
At $0.01, Immunovant, Inc.'s income tax per share ranks #115 of 199 in the Health Care sector. Income Tax per Share has increased for 4 consecutive years, from $-0.00 in FY2020 to $0.01 in FY2024.
Based on SEC 10-K filings.
0.01 in FY2024 with a 5-year CAGR of +21.2%.
Increased from $0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +21.2%
- 10-Year CAGR
- -
Sector benchmark
#115 of 199 in Health CareTop 57% of 199This company $0.01 Sector average $1.36
▼
-99.6% below sector average
Key checks
Key Insights
- Immunovant, Inc.'s income tax per share has grown for 4 consecutive years.
- In FY2024, income tax per share increased 43.2% year-over-year.
- Ranks #85 out of 199 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.01 | +43.2% |
| FY2023 | $0.00 | +5514.6% |
| FY2022 | $0.00 | +109.5% |
| FY2021 | -$0.00 | +81.2% |
| FY2020 | -$0.00 | -281.7% |
| FY2019 | $0.00 | +162.0% |
| FY2018 | $0.00 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026